Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 435

1.

A proposal for a comprehensive approach to infections across the surgical pathway.

Sartelli M, Pagani L, Iannazzo S, Moro ML, Viale P, Pan A, Ansaloni L, Coccolini F, D'Errico MM, Agreiter I, Amadio Nespola G, Barchiesi F, Benigni V, Binazzi R, Cappanera S, Chiodera A, Cola V, Corsi D, Cortese F, Crapis M, Cristini F, D'Arpino A, De Simone B, Di Bella S, Di Marzo F, Donati A, Elisei D, Fantoni M, Ferrari A, Foghetti D, Francisci D, Gattuso G, Giacometti A, Gesuelli GC, Marmorale C, Martini E, Meledandri M, Murri R, Padrini D, Palmieri D, Pauri P, Rebagliati C, Ricchizzi E, Sambri V, Schimizzi AM, Siquini W, Scoccia L, Scoppettuolo G, Sganga G, Storti N, Tavio M, Toccafondi G, Tumietto F, Viaggi B, Vivarelli M, Tranà C, Raso M, Labricciosa FM, Dhingra S, Catena F.

World J Emerg Surg. 2020 Feb 18;15(1):13. doi: 10.1186/s13017-020-00295-3. Review.

2.

Prediction of nosocomial acute-on-chronic liver failure in patients with cirrhosis admitted to hospital with acute decompensation.

Zaccherini G, Baldassarre M, Bartoletti M, Tufoni M, Berardi S, Tamè M, Napoli L, Siniscalchi A, Fabbri A, Marconi L, Antognoli A, Iannone G, Domenicali M, Viale P, Trevisani F, Bernardi M, Caraceni P.

JHEP Rep. 2019 Aug 1;1(4):270-277. doi: 10.1016/j.jhepr.2019.07.005. eCollection 2019 Oct.

3.

Follow-up blood cultures are associated with improved outcome of patients with gram-negative bloodstream infections: retrospective observational cohort study.

Giannella M, Pascale R, Pancaldi L, Monari C, Ianniruberto S, Malosso P, Bussini L, Bartoletti M, Tedeschi S, Ambretti S, Lewis R, Viale P.

Clin Microbiol Infect. 2020 Jan 29. pii: S1198-743X(20)30048-3. doi: 10.1016/j.cmi.2020.01.023. [Epub ahead of print]

PMID:
32006697
4.

Adaptive trials of new antimicrobials for infections with carbapenem-resistant, Gram-negative bacteria.

Gatti M, Giannella M, Scudeller L, Viale P.

Lancet Infect Dis. 2020 Jan;20(1):24. doi: 10.1016/S1473-3099(19)30704-2. No abstract available.

PMID:
31876495
5.

No progression of subclinical atherosclerosis in HIV-infected patients starting an initial regimen including tenofovir alafenamide/emtricitabine plus raltegravir, dolutegravir or elvitegravir/cobicistat during a two-year follow-up.

Calza L, Borderi M, Colangeli V, Borioni A, Coladonato S, Granozzi B, Viale P.

Infect Dis (Lond). 2020 Apr;52(4):249-256. doi: 10.1080/23744235.2019.1707279. Epub 2019 Dec 26.

PMID:
31876437
6.

Prognostic Utility of the New Definition of Difficult-to-Treat Resistance Among Patients With Gram-Negative Bloodstream Infections.

Giannella M, Bussini L, Pascale R, Bartoletti M, Malagrinò M, Pancaldi L, Toschi A, Ferraro G, Marconi L, Ambretti S, Lewis R, Viale P.

Open Forum Infect Dis. 2019 Dec 12;6(12):ofz505. doi: 10.1093/ofid/ofz505. eCollection 2019 Dec.

7.

Bloodstream infection caused by KPC-producing Klebsiella pneumoniae resistant to ceftazidime/avibactam: epidemiology and genomic characterization.

Gaibani P, Re MC, Campoli C, Viale PL, Ambretti S.

Clin Microbiol Infect. 2019 Nov 16. pii: S1198-743X(19)30610-X. doi: 10.1016/j.cmi.2019.11.011. [Epub ahead of print]

PMID:
31740422
8.

Advances in the therapy of bacterial bloodstream infections.

Giannella M, Bartoletti M, Gatti M, Viale P.

Clin Microbiol Infect. 2020 Feb;26(2):158-167. doi: 10.1016/j.cmi.2019.11.001. Epub 2019 Nov 14. Review.

PMID:
31733377
9.

Weight gain in antiretroviral therapy-naive HIV-1-infected patients starting a regimen including an integrase strand transfer inhibitor or darunavir/ritonavir.

Calza L, Colangeli V, Borderi M, Bon I, Borioni A, Volpato F, Re MC, Viale P.

Infection. 2019 Nov 12. doi: 10.1007/s15010-019-01376-5. [Epub ahead of print]

PMID:
31713814
10.

A multidrug resistant tuberculosis case treated with continuous infusion of meropenem in outpatient care.

Vanino E, Tadolini M, Attard L, Cascavilla A, Pea F, Viale P.

Int J Tuberc Lung Dis. 2019 Sep 1;23(9):1042. doi: 10.5588/ijtld.18.0829. No abstract available.

PMID:
31615614
11.

Genomic characterization of a Klebsiella pneumoniae ST1519 resistant to ceftazidime/avibactam carrying a novel KPC variant (KPC-36).

Gaibani P, Ambretti S, Campoli C, Viale P, Re MC.

Int J Antimicrob Agents. 2020 Jan;55(1):105816. doi: 10.1016/j.ijantimicag.2019.09.020. Epub 2019 Oct 5. No abstract available.

PMID:
31593765
12.

Use of meropenem in treating carbapenem-resistant Enterobacteriaceae infections.

Pascale R, Giannella M, Bartoletti M, Viale P, Pea F.

Expert Rev Anti Infect Ther. 2019 Oct;17(10):819-827. doi: 10.1080/14787210.2019.1673731. Epub 2019 Oct 8.

PMID:
31559876
13.

Ceftobiprole: drug evaluation and place in therapy.

Giacobbe DR, De Rosa FG, Del Bono V, Grossi PA, Pea F, Petrosillo N, Rossolini GM, Tascini C, Tumbarello M, Viale P, Bassetti M.

Expert Rev Anti Infect Ther. 2019 Sep;17(9):689-698. doi: 10.1080/14787210.2019.1667229. Epub 2019 Sep 25.

PMID:
31553250
14.

The Benefits of Nuts for Cancer Prevention.

Viale PH.

J Adv Pract Oncol. 2019 Mar;10(2):102-103. Epub 2019 Mar 1. No abstract available.

15.

Using State Transition Models to Explore How the Prevalence of Subtherapeutic Posaconazole Exposures Impacts the Clinical Utility of Therapeutic Drug Monitoring for Posaconazole Tablets and Oral Suspension.

Lewis RE, Kontoyiannis DP, Viale P, Sarpong EM.

Antimicrob Agents Chemother. 2019 Sep 16. pii: AAC.01435-19. doi: 10.1128/AAC.01435-19. [Epub ahead of print]

PMID:
31527039
16.

Screening for carriage of carbapenem-resistant Enterobacteriaceae in settings of high endemicity: a position paper from an Italian working group on CRE infections.

Ambretti S, Bassetti M, Clerici P, Petrosillo N, Tumietto F, Viale P, Rossolini GM.

Antimicrob Resist Infect Control. 2019 Aug 13;8:136. doi: 10.1186/s13756-019-0591-6. eCollection 2019. Review.

17.

Collection, transport and storage procedures for blood culture specimens in adult patients: recommendations from a board of Italian experts.

De Plato F, Fontana C, Gherardi G, Privitera GP, Puro V, Rigoli R, Viaggi B, Viale P.

Clin Chem Lab Med. 2019 Oct 25;57(11):1680-1689. doi: 10.1515/cclm-2018-1146.

PMID:
31348753
18.

Prevalence of chronic kidney disease among HIV-1-infected patients receiving a combination antiretroviral therapy.

Calza L, Sachs M, Colangeli V, Borderi M, Granozzi B, Malosso P, Comai G, Corradetti V, La Manna G, Viale P.

Clin Exp Nephrol. 2019 Nov;23(11):1272-1279. doi: 10.1007/s10157-019-01768-9. Epub 2019 Jul 20.

PMID:
31327092
19.

The Debate Over Alcohol Consumption: How Much Is Too Much?

Viale PH.

J Adv Pract Oncol. 2019 Jan-Feb;10(1):18-19. Epub 2019 Jan 1. No abstract available.

20.

Factors associated with vitamin D deficiency in HIV-1 infected patients on combination antiretroviral therapy: a case-control study.

Calza L, di Pietro G, Colangeli V, Borderi M, Zaghi I, Malosso P, Bon I, Re MC, Viale P.

New Microbiol. 2019 Jul;42(3):145-149. Epub 2019 Jul 15.

21.

Comparative serum bactericidal activity of meropenem-based combination regimens against extended-spectrum beta-lactamase and KPC-producing Klebsiella pneumoniae.

Gaibani P, Lombardo D, Bartoletti M, Ambretti S, Campoli C, Giannella M, Tedeschi S, Conti M, Mancini R, Landini MP, Re MC, Viale P, Lewis RE.

Eur J Clin Microbiol Infect Dis. 2019 Oct;38(10):1925-1931. doi: 10.1007/s10096-019-03628-6. Epub 2019 Jul 6.

PMID:
31278562
22.

18F-FDG PET/CT in visceral leishmaniasis: uptake patterns in the context of a multiannual outbreak in Northern Italy.

Zanoni L, Varani S, Attard L, Morigi JJ, Vanino E, Ortalli M, Fonti C, Viale P, Re MC, Fanti S, Ambrosini V.

Ann Nucl Med. 2019 Sep;33(9):716-723. doi: 10.1007/s12149-019-01381-6. Epub 2019 Jun 28.

PMID:
31254270
23.

Human Papillomavirus and Cancer.

Viale PH.

J Adv Pract Oncol. 2018 Nov-Dec;9(7):694-695. Epub 2018 Nov 1. No abstract available.

24.

Improvement in liver steatosis after the switch from a ritonavir-boosted protease inhibitor to raltegravir in HIV-infected patients with non-alcoholic fatty liver disease.

Calza L, Colangeli V, Borderi M, Coladonato S, Tazza B, Fornaro G, Badia L, Guardigni V, Verucchi G, Viale P.

Infect Dis (Lond). 2019 Aug;51(8):593-601. doi: 10.1080/23744235.2019.1629008. Epub 2019 Jun 20.

PMID:
31219362
25.

Use of colistin in adult patients: A cross-sectional study.

Giacobbe DR, Saffioti C, Losito AR, Rinaldi M, Aurilio C, Bolla C, Boni S, Borgia G, Carannante N, Cassola G, Ceccarelli G, Corcione S, Dalla Gasperina D, De Rosa FG, Dentone C, Di Bella S, Di Lauria N, Feasi M, Fiore M, Fossati S, Franceschini E, Gori A, Granata G, Grignolo S, Grossi PA, Guadagnino G, Lagi F, Maraolo AE, Marinò V, Mazzitelli M, Mularoni A, Oliva A, Pace MC, Parisini A, Patti F, Petrosillo N, Pota V, Raffaelli F, Rossi M, Santoro A, Tascini C, Torti C, Trecarichi EM, Venditti M, Viale P, Signori A, Bassetti M, Del Bono V, Giannella M, Mikulska M, Tumbarello M, Viscoli C; SITA GIOVANI (Young Investigators Group of the Società Italiana Terapia Antinfettiva) and the COLI-CROSS Study Group.

J Glob Antimicrob Resist. 2019 Jun 15;20:43-49. doi: 10.1016/j.jgar.2019.06.009. [Epub ahead of print]

26.

Control of Gram-negative multi-drug resistant microorganisms in an Italian ICU: Rapid decline as a result of a multifaceted intervention, including conservative use of antibiotics.

Frattari A, Savini V, Polilli E, Di Marco G, Lucisano G, Corridoni S, Spina T, Costantini A, Nicolucci A, Fazii P, Viale P, Parruti G.

Int J Infect Dis. 2019 Jul;84:153-162. doi: 10.1016/j.ijid.2019.04.002.

27.

Cancer and Obesity: Am I Part of the Problem?

Viale PH.

J Adv Pract Oncol. 2018 Sep-Oct;9(6):579-580. Epub 2018 Sep 1. No abstract available.

28.

Bloodstream infections caused by carbapenem-resistant Acinetobacter baumannii: Clinical features, therapy and outcome from a multicenter study.

Russo A, Bassetti M, Ceccarelli G, Carannante N, Losito AR, Bartoletti M, Corcione S, Granata G, Santoro A, Giacobbe DR, Peghin M, Vena A, Amadori F, Segala FV, Giannella M, Di Caprio G, Menichetti F, Del Bono V, Mussini C, Petrosillo N, De Rosa FG, Viale P, Tumbarello M, Tascini C, Viscoli C, Venditti M; ISGRI-SITA (Italian Study Group on Resistant Infections of the Società Italiana Terapia Antinfettiva).

J Infect. 2019 Aug;79(2):130-138. doi: 10.1016/j.jinf.2019.05.017. Epub 2019 May 28.

PMID:
31145911
29.

Presenting With Confidence.

Vogel WH, Viale PH.

J Adv Pract Oncol. 2018 Jul-Aug;9(5):545-548. Epub 2018 Jul 1. Review.

30.

The impact of carbapenemase-producing Enterobacteriaceae colonization on infection risk after liver transplantation: a prospective observational cohort study.

Giannella M, Bartoletti M, Campoli C, Rinaldi M, Coladonato S, Pascale R, Tedeschi S, Ambretti S, Cristini F, Tumietto F, Siniscalchi A, Bertuzzo V, Morelli MC, Cescon M, Pinna AD, Lewis R, Viale P.

Clin Microbiol Infect. 2019 Dec;25(12):1525-1531. doi: 10.1016/j.cmi.2019.04.014. Epub 2019 Apr 27.

PMID:
31039445
31.

Spondylodiscitis: is really all well defined?

Marchionni E, Marconi L, Ruinato D, Zamparini E, Gasbarrini A, Viale P.

Eur Rev Med Pharmacol Sci. 2019 Apr;23(2 Suppl):201-209. doi: 10.26355/eurrev_201904_17494.

32.

Clinical experience with dalbavancin for the treatment of deep sternal wound infection.

Bartoletti M, Mikus E, Pascale R, Giannella M, Tedeschi S, Calvi S, Tenti E, Tumietto F, Viale P.

J Glob Antimicrob Resist. 2019 Sep;18:195-198. doi: 10.1016/j.jgar.2019.03.015. Epub 2019 Mar 27.

PMID:
30926464
33.

The use of predictive scores in the management of patients with carbapenem-resistant Klebsiella pneumoniae infection.

Giannella M, Pascale R, Gutiérrez-Gutiérrez B, Cano A, Viale P.

Expert Rev Anti Infect Ther. 2019 Apr;17(4):265-273. doi: 10.1080/14787210.2019.1595590. Epub 2019 Mar 27.

PMID:
30876375
34.

2019 update of the WSES guidelines for management of Clostridioides (Clostridium) difficile infection in surgical patients.

Sartelli M, Di Bella S, McFarland LV, Khanna S, Furuya-Kanamori L, Abuzeid N, Abu-Zidan FM, Ansaloni L, Augustin G, Bala M, Ben-Ishay O, Biffl WL, Brecher SM, Camacho-Ortiz A, Caínzos MA, Chan S, Cherry-Bukowiec JR, Clanton J, Coccolini F, Cocuz ME, Coimbra R, Cortese F, Cui Y, Czepiel J, Demetrashvili Z, Di Carlo I, Di Saverio S, Dumitru IM, Eckmann C, Eiland EH, Forrester JD, Fraga GP, Frossard JL, Fry DE, Galeiras R, Ghnnam W, Gomes CA, Griffiths EA, Guirao X, Ahmed MH, Herzog T, Kim JI, Iqbal T, Isik A, Itani KMF, Labricciosa FM, Lee YY, Juang P, Karamarkovic A, Kim PK, Kluger Y, Leppaniemi A, Lohsiriwat V, Machain GM, Marwah S, Mazuski JE, Metan G, Moore EE, Moore FA, Ordoñez CA, Pagani L, Petrosillo N, Portela F, Rasa K, Rems M, Sakakushev BE, Segovia-Lohse H, Sganga G, Shelat VG, Spigaglia P, Tattevin P, Tranà C, Urbánek L, Ulrych J, Viale P, Baiocchi GL, Catena F.

World J Emerg Surg. 2019 Feb 28;14:8. doi: 10.1186/s13017-019-0228-3. eCollection 2019. Review.

35.

The burden of colonization and infection by carbapenemase-producing Enterobacteriaceae in the neuro-rehabilitation setting: a prospective six-year experience.

Tedeschi S, Trapani F, Liverani A, Tumietto F, Cristini F, Pignanelli S, Berlingeri A, Bonavita J, Belloni GP, Bartoletti M, Giannella M, Pederzini R, Viale P.

Infect Control Hosp Epidemiol. 2019 Mar;40(3):368-371. doi: 10.1017/ice.2018.344. Epub 2019 Feb 15.

PMID:
30767830
36.

Breast Cancer and Body Image Issues.

Viale PH.

J Adv Pract Oncol. 2018 May-Jun;9(4):375-376. Epub 2018 May 1. No abstract available.

37.

JADPRO Live at APSHO 2017: Precision Thinking, Practical Knowledge.

Viale PH.

J Adv Pract Oncol. 2018 Apr;9(3):270-271. Epub 2018 Apr 1. No abstract available.

38.

In vitro synergistic activity of meropenem/vaborbactam in combination with ceftazidime/avibactam against KPC-producing Klebsiella pneumoniae.

Gaibani P, Ambretti S, Viale P, Re MC.

J Antimicrob Chemother. 2019 May 1;74(5):1457-1459. doi: 10.1093/jac/dky557. No abstract available.

PMID:
30649310
39.

Extended Infusion of β-Lactams for Bloodstream Infection in Patients With Liver Cirrhosis: An Observational Multicenter Study.

Bartoletti M, Giannella M, Lewis RE, Caraceni P, Tedeschi S, Paul M, Schramm C, Bruns T, Merli M, Cobos-Trigueros N, Seminari E, Retamar P, Muñoz P, Tumbarello M, Burra P, Torrani Cerenzia M, Barsic B, Calbo E, Maraolo AE, Petrosillo N, Galan-Ladero MA, D'Offizi G, Zak-Doron Y, Rodriguez-Baño J, Baldassarre M, Verucchi G, Domenicali M, Bernardi M, Viale P; ESGBIS/BICHROME study group .

Clin Infect Dis. 2019 Oct 30;69(10):1731-1739. doi: 10.1093/cid/ciz032.

PMID:
30649218
40.

Risk factors for treatment failure in patients receiving β-lactam/β-lactamase inhibitor combinations for Enterobacteriaceae bloodstream infection: A retrospective, single-centre, cohort study.

Giannella M, Pascale R, Ferraro G, Toschi A, Pancaldi L, Furii F, Bartoletti M, Tedeschi S, Ambretti S, Lewis RE, Viale P.

Int J Antimicrob Agents. 2019 May;53(5):574-581. doi: 10.1016/j.ijantimicag.2019.01.005. Epub 2019 Jan 9.

PMID:
30639527
41.

Chemotherapy-Induced Nausea and Vomiting: Updates and Recommendations.

Viale PH.

J Adv Pract Oncol. 2018 Mar;9(2):150-152. Epub 2018 Mar 1. No abstract available.

42.

'Treatment duration for Escherichia coli bloodstream infection and outcomes' - Author's reply.

Giannella M, Pascale R, Viale P.

Clin Microbiol Infect. 2019 May;25(5):641-642. doi: 10.1016/j.cmi.2018.12.004. Epub 2018 Dec 21. No abstract available.

PMID:
30580033
43.

It's Just the Flu...or Is It?

Viale PH.

J Adv Pract Oncol. 2018 Jan-Feb;9(1):18-19. Epub 2018 Jan 1. No abstract available.

44.

2018 WSES/SIS-E consensus conference: recommendations for the management of skin and soft-tissue infections.

Sartelli M, Guirao X, Hardcastle TC, Kluger Y, Boermeester MA, Raşa K, Ansaloni L, Coccolini F, Montravers P, Abu-Zidan FM, Bartoletti M, Bassetti M, Ben-Ishay O, Biffl WL, Chiara O, Chiarugi M, Coimbra R, De Rosa FG, De Simone B, Di Saverio S, Giannella M, Gkiokas G, Khokha V, Labricciosa FM, Leppäniemi A, Litvin A, Moore EE, Negoi I, Pagani L, Peghin M, Picetti E, Pintar T, Pupelis G, Rubio-Perez I, Sakakushev B, Segovia-Lohse H, Sganga G, Shelat V, Sugrue M, Tarasconi A, Tranà C, Ulrych J, Viale P, Catena F.

World J Emerg Surg. 2018 Dec 14;13:58. doi: 10.1186/s13017-018-0219-9. eCollection 2018. Review.

45.

Improvement in insulin sensitivity and serum leptin concentration after the switch from a ritonavir-boosted PI to raltegravir or dolutegravir in non-diabetic HIV-infected patients.

Calza L, Colangeli V, Borderi M, Coladonato S, Tazza B, Bon I, Re MC, Viale P.

J Antimicrob Chemother. 2019 Mar 1;74(3):731-738. doi: 10.1093/jac/dky507.

PMID:
30541118
46.

Innovations in Cancer Therapies and Rising Costs.

Viale PH.

J Adv Pract Oncol. 2017 Nov-Dec;8(7):676-677. Epub 2017 Nov 1. No abstract available.

47.

Breast Implants and Lymphoma: What Is the Risk for Your Patient?

Viale PH.

J Adv Pract Oncol. 2017 Sep-Oct;8(6):565-567. Epub 2017 Sep 1. No abstract available.

48.

Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline viro-immunological status and outcome in patients under first-line ART.

Ceccherini-Silberstein F, Cozzi Lepri A, Alteri C, Merlini E, Surdo M, Marchetti G, Capobianchi MR, De Luca A, Gianotti N, Viale P, Andreoni M, Antinori A, Perno CF, d'Arminio Monforte A; ICONA Foundation Study Group.

J Antimicrob Chemother. 2018 Dec 1;73(12):3460-3470. doi: 10.1093/jac/dky350.

49.

The role of extended infusion β-lactams in the treatment of bloodstream infections in patients with liver cirrhosis.

Bartoletti M, Lewis RE, Giannella M, Tedeschi S, Viale P.

Expert Rev Anti Infect Ther. 2018 Oct;16(10):771-779. doi: 10.1080/14787210.2018.1523716. Epub 2018 Sep 26. Review.

PMID:
30221562
50.

Management of adverse events associated with idelalisib treatment in chronic lymphocytic leukemia and follicular lymphoma: A multidisciplinary position paper.

Cuneo A, Barosi G, Danesi R, Fagiuoli S, Ghia P, Marzano A, Montillo M, Poletti V, Viale P, Zinzani PL.

Hematol Oncol. 2019 Feb;37(1):3-14. doi: 10.1002/hon.2540. Epub 2018 Sep 5. Review.

Supplemental Content

Support Center